Clinical Trial Update: Safety and Efficacy of IDA for Onchocerciasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of IDA (Ivermectin, Diethylcarbamazine, and Albendazole) for Onchocerciasis has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onchocerciasis

Drugs mentioned

• IDA (Ivermectin + Diethylcarbamazine + Albendazole)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Onchocerciasis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-10